Streetbeat News

Analyst Ratings

D

Barclays analyst Nicholas Campanella has maintained an Overweight rating on Dominion Energy (NYSE:D) and increased the price target from $47 to $50.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 10:31 am

SWIM

Barclays analyst Matthew Bouley has maintained an Equal-Weight rating on Latham Group (NASDAQ:SWIM) and reduced the price target from $3 to $2.5.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 10:29 am

CLSD

Needham analyst Serge Belanger has reiterated a Buy rating on Clearside Biomedical (NASDAQ:CLSD) and maintained a $4 price target.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 10:29 am

BA

Wolfe Research analyst Myles Walton maintains an Outperform rating on Boeing (NYSE:BA) but lowers the price target from $270 to $260.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 10:28 am

HRTX

Needham analyst Serge Belanger has maintained a Buy rating on Heron Therapeutics (NASDAQ:HRTX) and increased the price target from $4 to $5.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 10:28 am

CELH

Jefferies analyst Kaumil Gajrawala maintains a Buy rating on Celsius Holdings (CELH) and raises the price target from $98 to $105.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 10:26 am

CLBT

William Blair analyst Jonathan Ho has upgraded Cellebrite DI (NASDAQ:CLBT) from Market Perform to Outperform, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 10:25 am

KSS

Goldman Sachs analyst Brooke Roach has maintained a Sell rating on Kohl's (NYSE:KSS) and kept the price target at $20. This reaffirms Goldman Sachs' bearish stance on the retail company.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 10:24 am

PAR

Goldman Sachs analyst Will Nance has maintained a Neutral rating on PAR Technology (NYSE:PAR) and increased the price target from $40 to $42.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 10:22 am

BILL

Exane BNP Paribas analyst Thomas Poutrieux upgraded BILL Holdings (NYSE:BILL) from Underperform to Neutral and set a $72 price target.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 10:21 am